Intermittent Claudication
📧 Sign up to get email alerts when something new happens for Intermittent Claudication.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-20Clinical Trial Update: Home-based Exercice Therapy for Patients With Intermittent Claudication Using a New Smartphone Application [NA]
This document reports a clinical trial evaluating a home-based exercise therapy delivered via a new smartphone application for patients with…
-
CLINICAL_TRIALS trial_result · 2024-11-14Clinical Trial Update: High Intensity Interval Training In pATiEnts With Intermittent Claudication [NA]
A completed clinical trial evaluating high-intensity interval training in patients with intermittent claudication due to peripheral arterial…
-
CLINICAL_TRIALS trial_result · 2024-08-26Clinical Trial Update: Upper Versus Lower Limb Exercises on Intermittent Claudication in Diabetic Patients [NA]
A completed clinical trial examined the effects of upper versus lower limb exercises on intermittent claudication in diabetic patients.
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Rivaroxaban 2.5 mg BID and Aspirin for Intermittent Claudication in PAD Patients [Phase 4]
A Phase 4 trial evaluating rivaroxaban 2.5 mg twice daily in combination with aspirin for intermittent claudication in patients with periphe…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Investigation of the Perfusion of Gluteal Muscle in Patients With Intermittent Gluteal Claudication by Non-invasive MSOT [NA]
This clinical trial update indicates a study is evaluating perfusion of the gluteal muscle in patients with intermittent gluteal claudicatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: Does Neuromuscular Electrical Stimulation Improve the Absolute Walking Distance in Patients With Intermittent Claudication Compared to Best Available Treatment? [NA]
Clinical trial assessing whether neuromuscular electrical stimulation improves absolute walking distance in intermittent claudication compar…
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: Randomized Phase IIb Trial of DVC1-0101 [Phase 2]
A randomized Phase IIb trial update for DVC1-0101 in intermittent claudication and peripheral arterial disease is reported, with the status …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease [Phase 4]
Phase 4 trial assessing the efficacy and safety of Sarpogrelate SR in chronic arterial occlusive disease and intermittent claudication has b…
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Clinical Trial for GNX80 in Intermittent Claudication [Phase 4]
A Phase 4 clinical trial update for GNX80 in intermittent claudication is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2021-02-15Clinical Trial Update: Exercise Rehabilitation in Veterans With PAD [NA]
A completed clinical trial evaluating exercise rehabilitation for veterans with peripheral arterial disease and intermittent claudication; r…
-
CLINICAL_TRIALS trial_result · 2021-01-07Clinical Trial Update: A Phase 2 Study of the Effects of Sapropterin Dihydrochloride on Symptomatic Peripheral Arterial Disease [Phase 2]
Phase 2 study evaluating the effects of sapropterin dihydrochloride on symptomatic peripheral arterial disease has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Evaluation of Musculoskeletal Microcirculation With Ultrasound [NA]
A terminated clinical trial evaluating musculoskeletal microcirculation using ultrasound in the context of standardized claudication treadmi…
-
FDA approval · 2020-11-16FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)
FDA approves a supplemental application for Cilostazol submitted by Apotex Corp., updating the drug's approval status.
-
FDA approval · 2020-11-02FDA Approved: PENTOXIFYLLINE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for pentoxifylline submitted by Rising Pharma Holdings, Inc., indicating an approved change related …
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: Investigating Superion™ In Spinal Stenosis [NA]
Clinical trial update for Superion in spinal stenosis shows completed status with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: Effect of Nike FuelBand on Exercise and Function in Claudicants; a Randomised Controlled Trial [NA]
Clinical trial examining the effect of a Nike FuelBand on exercise and function in individuals with intermittent claudication due to periphe…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication [Phase 2]
Phase 2 clinical trial of LLG783 in patients with peripheral artery disease and intermittent claudication has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Evaluating Two Exercise Training Programs to Reduce Leg Pain in People With Peripheral Arterial Disease (The EXERT Study) [Phase 3]
Phase 3 clinical trial evaluating two exercise training programs to reduce leg pain in people with intermittent claudication due to peripher…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease [Phase 1, Phase 2]
A clinical trial update for intramuscular FGF-1 in peripheral arterial disease has phases 1 and 2, with unspecified status.
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Neuromuscular Electrical Stimulation (NMES) in Patients With Intermittent Claudication [NA]
Completed clinical trial evaluating neuromuscular electrical stimulation in patients with intermittent claudication and peripheral vascular …
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Adjuvant Benefit of NMES to Supervised Exercise in Patients With IC [NA]
Clinical trial update reporting completed study on NMES added to supervised exercise for intermittent claudication, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule [Phase 2]
Phase 2 trial update evaluating Danshen Gegen (D&G) Capsule for intermittent claudication in peripheral arterial disease; completed study.
-
CLINICAL_TRIALS withdrawal · 2019-06-13Clinical Trial Update: ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion [Phase 4]
A Phase 4 trial titled 'ATHERO: Advanced Technology Halting Early Re-Stenosis and Occlusion' was withdrawn.
-
CLINICAL_TRIALS trial_result · 2019-05-14Clinical Trial Update: A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication [Phase 2]
Phase 2 clinical trial update for CK-2017357 in patients with intermittent claudication due to peripheral artery disease.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Creatine Supplementation in Patients With Intermittent Claudication. [NA]
Clinical trial update describes a study evaluating creatine supplementation in patients with intermittent claudication; no phase information…